BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rashidzadeh H, Tabatabaei Rezaei SJ, Adyani SM, Abazari M, Rahamooz Haghighi S, Abdollahi H, Ramazani A. Recent advances in targeting malaria with nanotechnology-based drug carriers. Pharm Dev Technol 2021;26:807-23. [PMID: 34190000 DOI: 10.1080/10837450.2021.1948568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadi E, Jamal Tabatabaei Rezaei S, Nedaei K, Ramazani A, Ramazani A. PEGylated Redox/pH Dual‐Responsive Dendritic Prodrugs Based on Boltorn® H40 for Tumor Triggered Paclitaxel Delivery. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202204246] [Reference Citation Analysis]
2 Yadav K, Singh D, Singh MR, Chauhan NS, Minz S, Pradhan M. Nanobiomaterials as novel modules in the delivery of artemisinin and its derivatives for effective management of malaria. Natural Products in Vector-Borne Disease Management 2023. [DOI: 10.1016/b978-0-323-91942-5.00003-3] [Reference Citation Analysis]
3 Rashidzadeh H, Mosavi FS, Shafiee T, Adyani SM, Eghlima G, Sanikhani M, Kheiry A, Amiri M, Tavakolizadeh M, Ramazani A. Anti-Plasmodial Effects of Different Ecotypes of Glycyrrhiza glabra Traditionally Used for Malaria in Iran. Rev Bras Farmacogn 2023;33:310-5. [PMID: 36687781 DOI: 10.1007/s43450-022-00353-8] [Reference Citation Analysis]
4 Khanmohammadi A, Sadighian S, Ramazani A. Anti-plasmodial effects of quinine-loaded magnetic nanocomposite coated with heparin. International Journal of Pharmaceutics 2022;628:122260. [DOI: 10.1016/j.ijpharm.2022.122260] [Reference Citation Analysis]
5 Chaves JB, Portugal Tavares de Moraes B, Regina Ferrarini S, Noé da Fonseca F, Silva AR, Gonçalves-de-albuquerque CF. Potential of nanoformulations in malaria treatment. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.999300] [Reference Citation Analysis]
6 Juneja M, Suthar T, Pardhi VP, Ahmad J, Jain K. Emerging trends and promises of nanoemulsions in therapeutics of infectious diseases. Nanomedicine (Lond) 2022. [PMID: 35587031 DOI: 10.2217/nnm-2022-0006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Najafzadeh M, Bakhshandeh H, Zamani Z, Movahedi M, Atyabi SM. Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum. Parasitol Res 2022;121:383-93. [PMID: 34993631 DOI: 10.1007/s00436-021-07395-2] [Reference Citation Analysis]
8 Mozafari F, Rashidzadeh H, Ghaffarlou M, Salehiabar M, Ertas YN, Ramazani A, Abazari M, Rahmati M, Javed Y, Sharma SK, Danafar H. ROS-Based Cancer Radiotherapy. Harnessing Materials for X-ray Based Cancer Therapy and Imaging 2022. [DOI: 10.1007/978-3-031-04071-9_10] [Reference Citation Analysis]